YD Bio Limited (NASDAQ:YDES – Get Free Report)’s share price dropped 17.7% during trading on Thursday . The company traded as low as $1.70 and last traded at $1.90. Approximately 345,138 shares were traded during trading, an increase of 414% from the average session volume of 67,181 shares. The stock had previously closed at $2.31.
YD Bio Stock Down 17.7%
The firm has a 50-day simple moving average of $3.88.
Institutional Trading of YD Bio
An institutional investor recently raised its position in YD Bio stock. Geode Capital Management LLC raised its position in shares of YD Bio Limited (NASDAQ:YDES – Free Report) by 10.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 58,363 shares of the biotechnology company’s stock after purchasing an additional 5,292 shares during the period. Geode Capital Management LLC owned approximately 0.08% of YD Bio worth $711,000 at the end of the most recent reporting period.
YD Bio Company Profile
YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.
See Also
- Five stocks we like better than YD Bio
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Receive News & Ratings for YD Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for YD Bio and related companies with MarketBeat.com's FREE daily email newsletter.
